Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 29

Results For "IDS"

347 News Found

Green chemistry approaches to synthesis could make a big difference to pharma product outputs
News | January 20, 2022

Green chemistry approaches to synthesis could make a big difference to pharma product outputs

Bio-catalysis and Electro-catalysis emerge as most preferred green chemistry technologies


Experts highlight positives of yoga in coping with Covid waves
Public Health | January 19, 2022

Experts highlight positives of yoga in coping with Covid waves

Yoga helps to build a strong immune system and daily breathing regime of 10-minute helps in the long run


TPVI offers a ray of hope for children with Pulmonic Valve disease
Hospitals | January 18, 2022

TPVI offers a ray of hope for children with Pulmonic Valve disease

Extending nonsurgical treatment options for Failing Pulmonic Valve in patients with congenital heart disease using Transcatheter Pulmonary Valve


We plan to move to other geographies as we expand: Jeya Kumar, Founder and MD, RaphaCure
interviews | January 17, 2022

We plan to move to other geographies as we expand: Jeya Kumar, Founder and MD, RaphaCure

The tele-heath market in India is expected to touch US $ 5.4 billion by 2025 and the adoption of tele-health has accelerated with the onset of Covid-19 in 2020. We caught up with Jeya Kumar, Founder and MD, RaphaCure, a prominent player in this segment and he outlined the opportunities that lie ahead for this segment


WHO recommends two new drugs for COVID-19
Drug Approval | January 14, 2022

WHO recommends two new drugs for COVID-19

Their strong recommendation is based on moderate certainty evidence that it improves survival and reduces the need for ventilation


Arch Pharmalabs signs agreement with Orchem Technologies to use SMB platform
News | January 10, 2022

Arch Pharmalabs signs agreement with Orchem Technologies to use SMB platform

Simulated Moving Bed (SMB) technology is a highly engineered process for implementing chromatographic separation


Clarivate identifies seven potential blockbuster drugs in Annual Drugs to Watch report
News | January 10, 2022

Clarivate identifies seven potential blockbuster drugs in Annual Drugs to Watch report

Despite the challenges of pandemic disruptions, drug developers advance promising therapies for conditions, including Alzheimer's, diabetes and asthma


Merck KGaA to acquire biopharma CDMO Exelead for $780 million
Biotech | January 07, 2022

Merck KGaA to acquire biopharma CDMO Exelead for $780 million

The transaction is expected to close in the first quarter of 2022


U.S. FDA approves Leo Pharma’s Adbry
Drug Approval | December 29, 2021

U.S. FDA approves Leo Pharma’s Adbry

Adbry is the first biologic launched by LEO Pharma in the United States and is expected to be available in pharmacies by February 2022


Expectations and predictions for 2022
Opinion | December 28, 2021

Expectations and predictions for 2022

In India, healthcare has become one of the fastest-growing economic sectors which comprise hospitals, pharma companies, medical equipment and devices, medical tourism, health insurance, clinical trials etc